(Q47368013)

http://europepmc.org/abstract/MED/27895323

14 January 2018

title

Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment. (English)

1 reference

http://europepmc.org/abstract/MED/27895323

14 January 2018

author

Udo Dannlowski

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Marin M Jukic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Tania Carrillo-Roa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Adrián Llerena

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Dominique de Quervain

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

Andreas Papassotiropoulos

6 June 2020

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Rachel F Tyndale

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

N Opel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

J Ström

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

S Miksys

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

M Novalen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

A Renblom

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

S C Sim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

E M Peñas-Lledó

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

P Courtet

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

B T Baune

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

E B Binder

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

M Ingelman-Sundberg

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

English

0 references

publication date

29 November 2016

1 reference

http://europepmc.org/abstract/MED/27895323

14 January 2018

published in

Molecular Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

1155-1163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/mp.2016.204

6 June 2020

exact match

0 references

cites work

Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

The organization of the stress system and its dysregulation in depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Corticosteroid responses to limbic stimulation in man: localization of stimulus sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Structural changes in hippocampal subfields in major depressive disorder: a high-field magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Hippocampal volume in healthy controls given 3-day stress doses of hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Association of depressive symptoms with hippocampal volume in 1936 adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Hippocampal atrophy in major depression: a function of childhood maltreatment rather than diagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Neurogenesis in the adult human hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Adult hippocampal neurogenesis buffers stress responses and depressive behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Experience dictates stem cell fate in the adult hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Early stress evokes age-dependent biphasic changes in hippocampal neurogenesis, BDNF expression, and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

The current state of the neurogenic theory of depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Molecular mechanisms in the regulation of adult neurogenesis during stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

5-HT1A receptors on mature dentate gyrus granule cells are critical for the antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Ventral hippocampal molecular pathways and impaired neurogenesis associated with 5-HT₁A and 5-HT₁B receptors disruption in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Chronic Treatment with the 5-HT1A Receptor Partial Agonist Tandospirone Increases Hippocampal Neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

5-HT1A receptor-regulated signal transduction pathways in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Cytochrome P450 enzymes in the brain: emerging evidence of biological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Generation of mice transgenic for human CYP2C18 and CYP2C19: characterization of the sexually dimorphic gene and enzyme expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Fluoxetine reverts chronic restraint stress-induced depression-like behaviour and increases neuropeptide Y and galanin expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Abnormal development of monoaminergic neurons is implicated in mood fluctuations and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Mice lacking NMDA receptors in parvalbumin neurons display normal depression-related behavior and response to antidepressant action of NMDAR antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Hippocampal gene expression changes underlying stress sensitization and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

A negative regulator of MAP kinase causes depressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Chronic imipramine treatment differentially alters the brain and plasma amino acid metabolism in Wistar and Wistar Kyoto rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Common genetic variants influence human subcortical brain structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Hippocampal volume in vulnerability and resilience to depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Serotonin-1A receptor imaging in recurrent depression: replication and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Increased serotonin release in mice frontal cortex and hippocampus induced by acute physiological stressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

Temperature regulation in depression: functional 5HT1A receptor adaptation differentiates antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

7 January 2021

Serotonin 5-HT1A receptors modulate hippocampal reactivity to afferent stimulation.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

7 January 2021

Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

7 January 2021

A comparison of biochemical indices of 5-hydroxytryptaminergic neuronal activity following electrical stimulation of the dorsal raphe nucleus.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

7 January 2021

Pharmacological characterization of BDNF promoters I, II and IV reveals that serotonin and norepinephrine input is sufficient for transcription activation

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.204

7 January 2021

Association between CYP2C19 polymorphism and depressive symptoms

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27895323

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/MP.2016.204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27895323%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference